CN106721918A - Astaxanthin green tea oral tablet - Google Patents
Astaxanthin green tea oral tablet Download PDFInfo
- Publication number
- CN106721918A CN106721918A CN201611041607.XA CN201611041607A CN106721918A CN 106721918 A CN106721918 A CN 106721918A CN 201611041607 A CN201611041607 A CN 201611041607A CN 106721918 A CN106721918 A CN 106721918A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- green tea
- powder
- parts
- oral tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 34
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 34
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 34
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 34
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 34
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 17
- 235000009569 green tea Nutrition 0.000 title claims abstract description 17
- 239000007935 oral tablet Substances 0.000 title claims abstract description 8
- 229940096978 oral tablet Drugs 0.000 title claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 22
- 241000758789 Juglans Species 0.000 claims abstract description 9
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 9
- 235000020234 walnut Nutrition 0.000 claims abstract description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 8
- 241000168517 Haematococcus lacustris Species 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000036449 good health Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 241000195493 Cryptophyta Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000168525 Haematococcus Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000583629 Cypridopsis vidua Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- -1 oxygen radical Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to field of health care food, specifically a kind of astaxanthin green tea oral tablet, including astaxanthin, green tea powder, walnut powder and excipient, it is characterized in that 36 parts of astaxanthin, 36 parts of green tea powder, 13 parts of walnut powder, excipient accounts for the 5 15% of total amount.The present invention has oxidation resistance, absorption efficiency is high, can significantly improve the features such as immunity of organisms, good health care effect and fragrant in taste.
Description
Technical field
The present invention relates to field of health care products, and in particular to a kind of astaxanthin green tea oral tablet.
Background technology
Astaxanthin (astaxanthin), also known as astaxanthin, Astaxanthin, are a Carotenoids, are also carotenoids
The highest level product of element synthesis, in rediance, chemical constitution is similar to beta carotene.And β-carrotene, lutein,
Canthaxanthin, lycopene etc. are all the intermediate products of carotenogenesis, therefore in nature, and astaxanthin has most strong anti-
Oxidisability.Content is higher during astaxanthin is widely present in the feather of living nature, particularly shrimp, crab, fish, frond, yeast and birds,
It is one of carotenoid main in marine organisms body.Only algae, saccharomycete and bacterium etc. can produce astaxanthin, higher
Deng animal can not be converted to this chemical constitution.
Natural astaxanthin is one of natural most strong in the world, and the oxygen radical in effective scavenger-cell increases
Strong cytothesis ability, maintains organism balance and reduces the accumulation of senile cell, and cell and DNA health are protected from inside to outside, from
And protect skin health, promote hair growth, anti-aging, alleviate sports fatigue, invigorate.Since two thousand eight, both at home and abroad
Numerous studies confirm that astaxanthin has stronger antioxidation activity, in enhance immunity, prevention of tumor, angiocardiopathy, glycosuria
The chronic diseases such as disease develop, and the aspect such as anti-aging has positive facilitation.
Natural astaxanthin antioxidation activity exceedes existing antioxidant.Its remove free radical ability be：Astaxanthin is dimension life
6000 times of effect of plain C；It is 1000 times of vitamin E；It is 800 times of Co-Q10；It is nitric oxide production 1800 times；It is to receive
3100 times of beans；It is 700 times of anthocyanidin；It is 100 times of beta carotene effect；It is 10 times of lycopene effect；It is yellow leaf
200 times of plain effect；It is 320 times of Tea Polyphenols effect.Natural astaxanthin also have one it is clear and definite the characteristics of, it is uniquely to pass through
One Carotenoids of blood-brain barrier.
Although astaxanthin has superpower oxidation resistance, because in the market overwhelming majority health products all directly use rain
Raw haematococcus algae powder, so that user often feels algae fishy smell like a hen on a hot girdle, has had a strong impact on people as primary raw material
To the acceptance level of astaxanthin product.Meanwhile, astaxanthin is liposoluble substance, and it is also current astaxanthin that how human body effectively absorbs
Use problem present in process.
The content of the invention
The shortcoming for bringing discomfort to user with algae fishy smell is absorbed in order to overcome astaxanthin to be difficult to, the present invention proposes a seed shrimp
Blue or green element green tea oral tablet.
The technical solution adopted for the present invention to solve the technical problems is：
A kind of astaxanthin green tea oral tablet, including astaxanthin（Haematococcus pluvialis powder）, green tea powder, walnut powder and excipient, it is special
It is astaxanthin 3-6 parts to levy, and green tea powder 3-6 parts, walnut powder 1-3 parts, excipient accounts for the 5-15% of total amount.
The present invention has oxidation resistance, absorption efficiency is high, can significantly improve immunity of organisms, good health care effect and mouth
The advantages of sense delicate fragrance.
Specific embodiment
Below, technical scheme is described in detail by specific embodiment.
A kind of astaxanthin green tea oral tablet, including astaxanthin（Haematococcus pluvialis powder）, green tea powder, walnut powder and excipient,
It is characterized in that astaxanthin（Haematococcus pluvialis powder）3-6 parts, green tea powder 3-6 parts, walnut powder 1-3 parts, excipient accounts for the 5- of total amount
15%.When edible, directly product of the invention be put into mouth and chewed, green tea largely discharges the delicate fragrance of tealeaves, rain in the oral cavity
The algae fishy smell of raw haematococcus itself is so as to be blanked.Simultaneously as walnut powder is oil food high, fat-soluble astaxanthin is can help to
Dissolving and the efficient absorption in gastrointestinal disturbances, so as to reach and give full play to astaxanthin by improving mouthfeel, improving absorptivity
Superpower oxidation resistance, strengthen body immunity, play a part of health care.
The present invention has oxidation resistance, absorption efficiency is high, can significantly improve immunity of organisms, good health care effect and mouth
The advantages of sense delicate fragrance.
The above, the only present invention preferably specific embodiment, but protection scope of the present invention is not limited thereto,
Any one skilled in the art the invention discloses technical scope in, technology according to the present invention scheme and its
Inventive concept is subject to equivalent or change, should all be included within the scope of the present invention.
Claims (1)
1. a kind of astaxanthin green tea oral tablet, including astaxanthin（Haematococcus pluvialis powder）, green tea powder, walnut powder and excipient, its
It it is characterized in astaxanthin 3-6 parts, green tea powder 3-6 parts, walnut powder 1-3 parts, excipient accounts for the 5-15% of total amount.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611041607.XA CN106721918A (en) | 2016-11-24 | 2016-11-24 | Astaxanthin green tea oral tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611041607.XA CN106721918A (en) | 2016-11-24 | 2016-11-24 | Astaxanthin green tea oral tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106721918A true CN106721918A (en) | 2017-05-31 |
Family
ID=58973965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611041607.XA Pending CN106721918A (en) | 2016-11-24 | 2016-11-24 | Astaxanthin green tea oral tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106721918A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109527496A (en) * | 2018-11-30 | 2019-03-29 | 海南职业技术学院 | A kind of preparation method of food composite nourishing energizing agent |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998610A (en) * | 2006-12-27 | 2007-07-18 | 陕西师范大学 | Antifatigue medicine contg. ombrophyte red chlorella |
| CN101854815A (en) * | 2007-09-07 | 2010-10-06 | 富士胶片株式会社 | Powder composition |
| CN104770740A (en) * | 2015-05-04 | 2015-07-15 | 威海御膳坊生物科技有限公司 | Haematococcus pluvialis and astaxanthin compound preparation |
-
2016
- 2016-11-24 CN CN201611041607.XA patent/CN106721918A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998610A (en) * | 2006-12-27 | 2007-07-18 | 陕西师范大学 | Antifatigue medicine contg. ombrophyte red chlorella |
| CN101854815A (en) * | 2007-09-07 | 2010-10-06 | 富士胶片株式会社 | Powder composition |
| CN104770740A (en) * | 2015-05-04 | 2015-07-15 | 威海御膳坊生物科技有限公司 | Haematococcus pluvialis and astaxanthin compound preparation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109527496A (en) * | 2018-11-30 | 2019-03-29 | 海南职业技术学院 | A kind of preparation method of food composite nourishing energizing agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106107396A (en) | A kind of antioxidation solid beverage containing Haematocoocus Pluvialls black currant powder | |
| Marzieh Hosseini et al. | Spirulina paltensis: Food and function | |
| RU2006132336A (en) | COMPOSITIONS CONTAINING CIS-ISOMERS OF A CAROTINOID COMPOUND AND METHOD FOR PRODUCING THEM | |
| Bogacz-Radomska et al. | Commercialization aspects of carotenoids | |
| CN103719301A (en) | Healthy food taking astaxanthin oil as main material | |
| CN103503952A (en) | Gadus dried meat floss cake | |
| CN101449824A (en) | Blueberry rose-hip bee pollen food | |
| CN102362682B (en) | Tomato and egg soup stock | |
| CN106309316A (en) | All-natural lipstick containing no castor oil or synthetic raw materials | |
| CN106721918A (en) | Astaxanthin green tea oral tablet | |
| JPWO2016104487A1 (en) | Carotenoid mass production method | |
| CN107251947A (en) | A kind of Astaxanthin In Haematococcus Pluvialis milk and preparation method thereof | |
| CN101069709A (en) | Nutrient health-care capsule | |
| CN101861960B (en) | Pearl freckle dispelling aesthetic health care food | |
| CN107647089A (en) | A kind of non-harmful lobster feed | |
| CN107772190A (en) | A kind of Astaxanthin In Haematococcus Pluvialis product formula for improving puerpera and infant immunity | |
| CN106190722A (en) | A kind of astaxanthin yellow wine and preparation method thereof | |
| CN104757586A (en) | Baked herbal soaked egg food with nuts and preparation method thereof | |
| JP6049108B2 (en) | Awakening time extender | |
| KR101618110B1 (en) | The picked radish containing natural-pigment and flavore | |
| KR20140080251A (en) | Food composition for improving or preventing intestinal function | |
| CN108013438A (en) | A kind of health-care food contg. Chinese caterpillar fungus and its preparation process | |
| CN109430832A (en) | A kind of edible gel products and preparation method thereof of astaxanthin and dendrobium candidum combination | |
| CN106085812A (en) | A kind of astaxanthin vinegar and preparation method thereof | |
| CN102771565A (en) | Purple sweet potato milk and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |
|
| RJ01 | Rejection of invention patent application after publication |